Jordan Smith, D.O. Surgery Medicare: Accepting Medicare Assignments Practice Location: 1550 S Pioneer Way, Moses Lake, WA 98837 Phone: 509-793-9792 Fax: 509-764-3287 |
Louis F. Martin, M.D. Surgery Medicare: Not Enrolled in Medicare Practice Location: 1550 S Pioneer Way, Suite 370, Moses Lake, WA 98837 Phone: 509-764-2928 Fax: 509-764-2929 |
Rodney E Grolman, MD Surgery Medicare: Accepting Medicare Assignments Practice Location: 1550 S Pioneer Way, Suite 370, Moses Lake, WA 98837 Phone: 410-218-8059 |
Andrea Matson, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 1550 S Pioneer Way, Moses Lake, WA 98837 Phone: 509-793-9792 Fax: 509-764-3287 |
Eric Ebaugh, DO Surgery Medicare: Accepting Medicare Assignments Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-663-8711 |
Allen D Rolfs, MD Surgery Medicare: Not Enrolled in Medicare Practice Location: 840 E Hill Ave, Moses Lake, WA 98837 Phone: 509-765-0216 |
News Archive
Oral health has been called the window to one's overall health, and a new national research effort led by the University of Alabama at Birmingham School of Dentistry aims to provide people on the frontline of oral health care - community dentists in private practice - the opportunity to be on the forefront of research that addresses day-to-day issues they face with patients. The effort not only could improve the nation's dental health but its overall health as well.
Prometheus Laboratories Inc., a specialty pharmaceutical and diagnostic company, today announced that it has executed a $260 million senior secured credit facility. The credit facility consists of a $210 million term loan and a $50 million revolving credit line.
BioLineRx, a biopharmaceutical development company, announced today that BL-8040 has been shown in pre-clinical trials to be effective for the treatment of thrombocytopenia, or reduced platelet production.
EMD Millipore, the Life Science division of Merck KGaA of Darmstadt, Germany, and iPS Academia Japan, Inc. today announced a global licensing agreement for AJ's induced pluripotent stem (iPS) cell patent portfolio.
› Verified 8 days ago